(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
People mailed a free stool test kit are three times more likely to undergo colon cancer screening About 30% of patients sent a free kit completed their screening within six months By comparison ...